Summit Therapeutics, Inc. (SMMT)
17.54
+0.05
(+0.29%)
USD |
NASDAQ |
Jan 02, 16:00
17.54
0.00 (0.00%)
After-Hours: 17:12
Summit Therapeutics Total Assets (Quarterly): 261.73M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 1.362B |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Arrowhead Pharmaceuticals, Inc. | 1.450B |
| Insmed, Inc. | 2.361B |
| CorMedix, Inc. | 750.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 69.47M |
| Shareholders Equity (Quarterly) | 192.26M |
| Debt to Equity Ratio | 0.0282 |
| Current Ratio | 3.796 |
| Net Debt Paydown Yield | 0.13% |